126 related articles for article (PubMed ID: 36549455)
1. Interaction of C-terminal p53 isoforms depends strongly upon DNA sequence and topology.
Goswami P; Šislerová L; Dobrovolná M; Havlík J; Šťastný J; Brázda V
Biochimie; 2023 May; 208():93-99. PubMed ID: 36549455
[TBL] [Abstract][Full Text] [Related]
2. Modulation of p53β and p53γ expression by regulating the alternative splicing of TP53 gene modifies cellular response.
Marcel V; Fernandes K; Terrier O; Lane DP; Bourdon JC
Cell Death Differ; 2014 Sep; 21(9):1377-87. PubMed ID: 24926616
[TBL] [Abstract][Full Text] [Related]
3. The Influence of Quadruplex Structure in Proximity to P53 Target Sequences on the Transactivation Potential of P53 Alpha Isoforms.
Porubiaková O; Bohálová N; Inga A; Vadovičová N; Coufal J; Fojta M; Brázda V
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878115
[TBL] [Abstract][Full Text] [Related]
4. p53 isoforms differentially impact on the POLι dependent DNA damage tolerance pathway.
Guo Y; Rall-Scharpf M; Bourdon JC; Wiesmüller L; Biber S
Cell Death Dis; 2021 Oct; 12(10):941. PubMed ID: 34645785
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of p53beta and p53gamma, two isoforms of the tumor suppressor p53.
Graupner V; Schulze-Osthoff K; Essmann F; Jänicke RU
Cell Cycle; 2009 Apr; 8(8):1238-48. PubMed ID: 19305147
[TBL] [Abstract][Full Text] [Related]
6. Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance.
Guo Y; Wu H; Wiesmüller L; Chen M
Cell Death Dis; 2024 Jun; 15(6):412. PubMed ID: 38866752
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
[TBL] [Abstract][Full Text] [Related]
8. Caffeine induces tumor cytotoxicity via the regulation of alternative splicing in subsets of cancer-associated genes.
Lu GY; Huang SM; Liu ST; Liu PY; Chou WY; Lin WS
Int J Biochem Cell Biol; 2014 Feb; 47():83-92. PubMed ID: 24333670
[TBL] [Abstract][Full Text] [Related]
9. Expression of TP53 isoforms p53β or p53γ enhances chemosensitivity in TP53(null) cell lines.
Silden E; Hjelle SM; Wergeland L; Sulen A; Andresen V; Bourdon JC; Micklem DR; McCormack E; Gjertsen BT
PLoS One; 2013; 8(2):e56276. PubMed ID: 23409163
[TBL] [Abstract][Full Text] [Related]
10. Species-specific regulation of alternative splicing in the C-terminal region of the p53 tumor suppressor gene.
Laverdière M; Beaudoin J; Lavigueur A
Nucleic Acids Res; 2000 Mar; 28(6):1489-97. PubMed ID: 10684946
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor protein p53 binds preferentially to supercoiled DNA.
Palecek E; Vlk D; Stanková V; Brázda V; Vojtesek B; Hupp TR; Schaper A; Jovin TM
Oncogene; 1997 Oct; 15(18):2201-9. PubMed ID: 9393978
[TBL] [Abstract][Full Text] [Related]
12. On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding.
Cesková P; Chichger H; Wallace M; Vojtesek B; Hupp TR
J Mol Biol; 2006 Mar; 357(2):442-56. PubMed ID: 16438982
[TBL] [Abstract][Full Text] [Related]
13. Specific interaction of p53 with target binding sites is determined by DNA conformation and is regulated by the C-terminal domain.
Göhler T; Reimann M; Cherny D; Walter K; Warnecke G; Kim E; Deppert W
J Biol Chem; 2002 Oct; 277(43):41192-203. PubMed ID: 12171916
[TBL] [Abstract][Full Text] [Related]
14. Identification of nonsense-mediated mRNA decay pathway as a critical regulator of p53 isoform β.
Cowen LE; Tang Y
Sci Rep; 2017 Dec; 7(1):17535. PubMed ID: 29235495
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Influence of a G-Quadruplex Prone Sequence on the Transactivation Potential by Wild-Type and/or Mutant P53 Family Proteins through a Yeast-Based Functional Assay.
Monti P; Brazda V; Bohálová N; Porubiaková O; Menichini P; Speciale A; Bocciardi R; Inga A; Fronza G
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33672023
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nonsense-mediated decay rescues p53β/γ isoform expression and activates the p53 pathway in MDM2-overexpressing and select p53-mutant cancers.
Gudikote JP; Cascone T; Poteete A; Sitthideatphaiboon P; Wu Q; Morikawa N; Zhang F; Peng S; Tong P; Li L; Shen L; Nilsson M; Jones P; Sulman EP; Wang J; Bourdon JC; Johnson FM; Heymach JV
J Biol Chem; 2021 Nov; 297(5):101163. PubMed ID: 34481841
[TBL] [Abstract][Full Text] [Related]
17. The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity.
Bayle JH; Elenbaas B; Levine AJ
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5729-33. PubMed ID: 7777576
[TBL] [Abstract][Full Text] [Related]
18. Interaction of p53 with its consensus DNA-binding site.
Wang Y; Schwedes JF; Parks D; Mann K; Tegtmeyer P
Mol Cell Biol; 1995 Apr; 15(4):2157-65. PubMed ID: 7891710
[TBL] [Abstract][Full Text] [Related]
19. The C terminus of p53 family proteins is a cell fate determinant.
Harms KL; Chen X
Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
[TBL] [Abstract][Full Text] [Related]
20. The single-stranded DNA end binding site of p53 coincides with the C-terminal regulatory region.
Selivanova G; Iotsova V; Kiseleva E; Ström M; Bakalkin G; Grafström RC; Wiman KG
Nucleic Acids Res; 1996 Sep; 24(18):3560-7. PubMed ID: 8836183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
